Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoximone in Acute Exacerbation COPD
NCT04420455Phase 4Terminated
- Sponsor
- Rijnstate
- Start
- May 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enoximone in chronic obstructive pulmonary disease (COPD), sponsored by Rijnstate. Started May 2020; status: terminated.
02
Drugs
enoximone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04420455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420455.